Here, increased cell cycle mutations and the activation of E2F and G2M pathways related with CIN and poor prognosis and drug resistance were also determined in LUSC patients with TP53/LRP1B mutant [38,53]. The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.